Susquehanna International Group, LLP Selecta Biosciences Inc Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

A detailed history of Susquehanna International Group, LLP transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 45,150 shares of SELB stock, worth $37,926. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,150

Previous 161,045 71.96%

Holding current value

$37,926

Previous $111,000 66.67%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$0.62 - $0.85 $71,854 - $98,510	-115,895 Reduced 71.96%	45,150 $37,000
Q4 2023 Feb 14, 2024	BUY	$0.67 - $1.35 $107,900 - $217,410	161,045 New	161,045 $111,000
Q2 2023 Aug 11, 2023	SELL	$1.04 - $1.4 $837,339 - $1.13 Million	-805,134 Reduced 95.73%	35,937 $40,000
Q1 2023 May 16, 2023	BUY	$1.15 - $1.89 $943,449 - $1.55 Million	820,391 Added 3967.07%	841,071 $1.17 Million
Q4 2022 Feb 14, 2023	SELL	$0.96 - $1.6 $16,428 - $27,380	-17,113 Reduced 45.28%	20,680 $23,000

Q3 2022 Nov 14, 2022	SELL	$1.33 - $2.6 $131,457 - $256,984	-98,840 Reduced 72.34%	37,793 $61,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $1.4 $66,440 - $138,831	99,165 Added 264.67%	136,633 $179,000
Q1 2022 May 16, 2022	SELL	$1.23 - $3.31 $134,384 - $361,637	-109,256 Reduced 74.46%	37,468 $46,000
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $40,928 - $62,737	-14,162 Reduced 8.8%	146,724 $478,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.62 $405,232 - $557,195	120,605 Added 299.41%	160,886 $669,000
Q2 2021 Aug 11, 2021	BUY	$2.82 - $5.01 $67,319 - $119,598	23,872 Added 145.48%	40,281 $168,000
Q4 2020 Feb 16, 2021	BUY	$1.64 - $3.42 $7,466 - $15,571	4,553 Added 38.4%	16,409 $50,000
Q3 2020 Nov 16, 2020	SELL	$2.18 - $2.84 $603,369 - $786,041	-276,775 Reduced 95.89%	11,856 $29,000
Q1 2020 May 15, 2020	BUY	$1.5 - $4.52 $432,946 - $1.3 Million	288,631 New	288,631 $696,000
Q1 2019 May 15, 2019	SELL	$1.47 - $3.06 $18,663 - $38,849	-12,696 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$2.66 - $15.93 $120,298 - $720,434	-45,225 Reduced 78.08%	12,696 $34,000
Q3 2018 Nov 14, 2018	BUY	$12.07 - $16.0 $699,106 - $926,736	57,921 New	57,921 $901,000
Q2 2018 Aug 14, 2018	SELL	$9.36 - $13.25 $188,753 - $267,199	-20,166 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.49 - $11.82 $171,209 - $238,362	20,166 New	20,166 $205,000

Others Institutions Holding SELB

# of Institutions

Shares Held

41.4M

Call Options Held

16.8K

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Selecta Biosciences Inc Transaction History